Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Understanding and controlling amyloid aggregation with chirality

Current Opinion in Chemical Biology(2021)10.1016/j.cbpa.2021.01.003Source: DataRank Database

Understanding and controlling amyloid aggregation with chirality is a research paper published in Current Opinion in Chemical Biology (2021). On theSindex it has a DataRank of 0. It has been cited 25 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access25 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 2.51)OA: greenTopics (62)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Jevgenij A. Raskatov ORCID,Alejandro R. Foley ORCID

Live enrichment

PubMed:33610939 PMC:PMC8368077 OpenAlex:https://openalex.org/W3131247236

University of California, Santa Cruz

Grant: R21AG058074

NIA NIH HHS

Grant: R01 AG074954

NIGMS NIH HHS

Grant: R25 GM058903

National Institutes of Health

Grant: 1R21AG058074-01

Chiral Inactivation of Amyloid beta Actions in Cytotoxicity, Synaptic transmission and Plasticity

National Institutes of Health

Grant: 5R25GM058903-05

University of California, Santa Cruz, IMSD Program

University of California

National Institutes of Health

FWCI

2.51

Citation Percentile

0.9%

Citation Trend

2021

2022

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8368077

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368077

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8368077

publisherhttps://api.elsevier.com/content/article/PII:S136759312100003X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S136759312100003X?httpAccept=text/plain

Fields of Study

Alzheimer's disease research and treatmentsSupramolecular Self-Assembly in MaterialsProtein Structure and DynamicsMedicineChemistry02 engineering and technology01 natural sciences0104 chemical sciences0210 nano-technologyAmino Acid SequenceAmyloidAmyloid beta-PeptidesDiabetes Mellitus, Type 2HumansPeptides

MeSH Terms

Amino Acid SequenceAmyloidDiabetes Mellitus, Type 2HumansPeptidesAmyloid beta-Peptides

Keywords

Amyloid (mycology)Amyloid fibrilProtein aggregationComputational biologyFibrilPeptideBiochemistry of Alzheimer's diseaseDiseaseChemistryBiologyAmyloid precursor proteinNeuroscienceBiochemistryAmyloid βAlzheimer's diseaseMedicineAmyloidChiralityMirror-image PeptidesModulation Of Aggregation PathwaysAgingNeurodegenerativeMedicinal and Biomolecular ChemistryAcquired Cognitive ImpairmentDiabetes Mellitus2.1 Biological and endogenous factorsHumansAmino Acid SequenceAetiologyAmyloid beta-PeptidesOrganic ChemistryNeurosciencesAlzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)Biological SciencesBrain DisordersDiabetes Mellitus, Type 2Biochemistry and cell biologyNeurologicalDementiaPeptidesType 2

Sustainable Development Goals

SDG 0: Good health and well-being